Altria on! PLUS Nationwide Rollout
Key Questions
What is Altria's on! PLUS pouch rollout?
Altria has launched FDA-authorized on! PLUS pouches nationwide through Helix starting March 23, 2026, available in three flavors and two strengths. The expansion has been confirmed, boosting Altria's position in reduced-risk products (RRPs).
What were the Q4 sales figures for on! pouches?
In Q4, on! pouches sold 177.8 million cans, marking an 11% increase and achieving a 13.4% market share. This growth occurred despite a 6.1% decline in cigarette sales.
How does Altria's pouch performance compare to traditional cigarettes?
on! pouches saw 11% volume growth to 177.8 million cans in Q4, capturing 13.4% market share, while cigarette sales declined by 6.1%. This highlights the shift toward modern oral nicotine products.
What recent competitive developments intensify pouch market competition?
British American Tobacco (BAT) debuted new generation products (NGP) and Al Fakher at an expo, escalating pouch wars. Altria maintains an edge due to FDA stalls on competitors like PMI and BTI.
Why does FDA stalling benefit Altria over competitors?
FDA delays on fast-tracks, pilots, and MRTPAs for products like ZYN, Velo, and on! reinforce Altria's RRP advantage against PMI and BTI. Bureaucratic foot-dragging hinders competitors' growth opportunities.
Altria's FDA-authorized on! PLUS pouches nationwide via Helix since 3/23/26, three flavors/two strengths; expansion confirmed. Q4 177.8M cans +11%, 13.4% share despite cig -6.1%. BAT NGP and Al Fakher expo debut intensify pouch wars; FDA stalls reinforce Altria RRP edge vs PMI/BTI.